Y-mAbs Therapeutics, Inc. (YMAB) Ownership

$6.89

south_east
-$0.5 (-6.77%)
Day's range
$6.84
Day's range
$7.38

Y-mAbs Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
PARADIGM BIOCAPITAL ADVISORS LP 11/14/2024 4.09 M $53.74 M   5.57% 9.16%
BLACKROCK FUNDING, INC. /DE 11/13/2024 3.03 M $39.78 M   100.00% 6.78%
SOFINNOVA INVESTMENTS, INC. 11/13/2024 2.19 M $28.85 B   0.00% 4.92%
VANGUARD GROUP INC 11/13/2024 2.04 M $26.77 M   3.99% 4.56%
POLAR CAPITAL HOLDINGS PLC 11/14/2024 1.83 M $24.08 M   0.00% 4.10%
CORMORANT ASSET MANAGEMENT, LP 11/14/2024 1.45 M $19.07 M   0.00% 3.25%
STATE STREET CORP 11/14/2024 1.21 M $15.91 M   50.36% 2.71%
CALIGAN PARTNERS LP 11/14/2024 1.20 M $15.72 M   105.34% 2.68%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 813,489 $10.70 M   6.25% 1.82%
LOGOS GLOBAL MANAGEMENT LP 11/14/2024 800,000 $10.52 M   100.00% 1.79%
D. E. SHAW & CO., INC. 11/14/2024 787,536 $10.36 M   -14.99% 1.76%
PICTET ASSET MANAGEMENT HOLDING SA 11/12/2024 687,980 $9.05 M   4.29% 1.54%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2024 557,429 $7.33 M   50.92% 1.25%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 477,664 $6.28 M   -1.40% 1.07%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2024 399,982 $5.26 M   -38.27% 0.90%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 279,577 $3.68 M   9.38% 0.63%
CITADEL ADVISORS LLC 11/14/2024 274,547 $3.61 M   4.89% 0.62%
MORGAN STANLEY 11/14/2024 248,722 $3.27 M   22.44% 0.56%
GOLDMAN SACHS GROUP INC 11/14/2024 222,600 $2.93 M   60.45% 0.50%
SQUAREPOINT OPS LLC 11/14/2024 154,931 $2.04 M   22.58% 0.35%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/14/2024 149,681 $1.97 M   0.00% 0.34%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2024 136,714 $1.80 M   -14.79% 0.31%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 112,483 $1.48 M   0.00% 0.25%
RICE HALL JAMES & ASSOCIATES, LLC 10/28/2024 108,684 $1.43 M   21.12% 0.24%
ACADIAN ASSET MANAGEMENT LLC 11/12/2024 105,777 $1.39 M   -67.27% 0.24%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2024 95,383 $1.25 M   -73.43% 0.21%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/08/2024 94,225 $1.24 M   -46.48% 0.21%
BANK OF NEW YORK MELLON CORP 11/12/2024 91,555 $1.20 M   -24.31% 0.21%
TWO SIGMA ADVISERS, LP 11/14/2024 85,000 $1.12 M   -13.00% 0.19%
BANK OF AMERICA CORP /DE/ 11/14/2024 79,720 $1.05 M   78.41% 0.18%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2024 76,000 $999,400   0.00% 0.17%
MILLENNIUM MANAGEMENT LLC 11/14/2024 71,586 $941,356   -79.53% 0.16%
BARCLAYS PLC 11/19/2024 69,222 $910,000   433.38% 0.16%
FRANKLIN RESOURCES INC 11/27/2024 67,289 $978,382   0.47% 0.15%
TWO SIGMA INVESTMENTS, LP 11/14/2024 67,141 $882,904   9.50% 0.15%
SWISS NATIONAL BANK 11/07/2024 60,300 $792,945   0.00% 0.14%
CAMPBELL & CO INVESTMENT ADVISER LLC 11/12/2024 56,590 $744,159   -8.79% 0.13%
STATE OF WISCONSIN INVESTMENT BOARD 11/14/2024 55,668 $732,034   35.09% 0.12%
ALLIANCEBERNSTEIN L.P. 11/14/2024 54,780 $720,357   -5.78% 0.12%
RHUMBLINE ADVISERS 11/12/2024 52,315 $687,932   -3.78% 0.12%
UBS GROUP AG 11/14/2024 44,586 $586,305   134.61% 0.10%
SAPIENT CAPITAL LLC 10/11/2024 43,700 $574,655   0.00% 0.10%
STRS OHIO 11/01/2024 43,400 $570,710   0.00% 0.10%
LEGAL & GENERAL GROUP PLC 11/14/2024 37,695 $495,690   3.05% 0.08%
FMR LLC 11/13/2024 36,416 $478,870   23.05% 0.08%
RAFFERTY ASSET MANAGEMENT, LLC 11/13/2024 35,077 $461,263   100.00% 0.08%
ALPS ADVISORS INC 11/12/2024 34,231 $450,138   0.02% 0.08%
JPMORGAN CHASE & CO 12/26/2024 30,335 $398,906   10.39% 0.07%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 11/14/2024 29,481 $387,675   -3.18% 0.07%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 27,900 $366,885   -56.84% 0.06%

Y-mAbs Therapeutics, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of YMAB shares?

During the previous two years, 126 institutional investors and hedge funds held shares of Y-mAbs Therapeutics, Inc.. The most heavily invested institutionals were:

Paradigm Biocapital Advisors LP: 4.09 M

BlackRock Funding, Inc. /DE: 3.03 M

Sofinnova Investments, Inc.: 2.19 M

VANGUARD GROUP INC: 2.04 M

Polar Capital Holdings Plc: 1.83 M

Cormorant Asset Management, LP: 1.45 M

What percentage of Y-mAbs Therapeutics, Inc. stock is owned by institutional investors?

57.68% of Y-mAbs Therapeutics, Inc. stock is owned by institutional investors.

How much institutional buying is happening at YMAB ?

Institutional investors have bought a total of 29.07 M shares in the last 24 months. This purchase volume represents approximately $200.26 M in transactions.